The milestone 400th transplant was a haploidentical allogeneic procedure conducted on a patient with acute myeloid leukemia (AML), using stem cells donated by the patient’s daughter. Haploidentical transplants, requiring only a partial tissue-type match between donor and recipient, have broadened the scope of family-based donations, enhancing access for patients in need.
Of the 400 transplants, 220 were allogeneic, utilizing donor stem cells, and 180 were autologous, employing the patient’s own cells. The primary conditions treated include acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes, all serious hematologic malignancies. The hospital has consistently enhanced the safety and effectiveness of these procedures, leveraging extensive expertise in pre- and post-transplant care.
Patients typically undergo chemotherapy in the semi-sterile rooms before being transferred to the transplant ward for the procedure. A team of expert physicians and skilled nurses provides continuous care to optimize patient outcomes.
Dr. Taek Lee, president of Inha University Hospital, highlighted the procedure’s complexity, stating, “Hematopoietic stem cell transplantation demands successful chemotherapy, dependable donor availability, and trust in our medical team. We prioritize patient safety, carefully overseeing every stage of the process, and strive to be a trusted institution for those battling severe blood disorders.”
Lim Hye Jung, HEALTH IN NEWS TEAM
press@hinews.co.kr
